20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Role of Mitochondria in the Mechanisms of Cardiac Ischemia-Reperfusion Injury

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mitochondria play a critical role in maintaining cellular function by ATP production. They are also a source of reactive oxygen species (ROS) and proapoptotic factors. The role of mitochondria has been established in many aspects of cell physiology/pathophysiology, including cell signaling. Mitochondria may deteriorate under various pathological conditions, including ischemia-reperfusion (IR) injury. Mitochondrial injury can be one of the main causes for cardiac and other tissue injuries by energy stress and overproduction of toxic reactive oxygen species, leading to oxidative stress, elevated calcium and apoptotic and necrotic cell death. However, the interplay among these processes in normal and pathological conditions is still poorly understood. Mitochondria play a critical role in cardiac IR injury, where they are directly involved in several pathophysiological mechanisms. We also discuss the role of mitochondria in the context of mitochondrial dynamics, specializations and heterogeneity. Also, we wanted to stress the existence of morphologically and functionally different mitochondrial subpopulations in the heart that may have different sensitivities to diseases and IR injury. Therefore, various cardioprotective interventions that modulate mitochondrial stability, dynamics and turnover, including various pharmacologic agents, specific mitochondrial antioxidants and uncouplers, and ischemic preconditioning can be considered as the main strategies to protect mitochondrial and cardiovascular function and thus enhance longevity.

          Related collections

          Most cited references150

          • Record: found
          • Abstract: found
          • Article: not found

          Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

          Bcl-2 is an integral membrane protein located mainly on the outer membrane of mitochondria. Overexpression of Bcl-2 prevents cells from undergoing apoptosis in response to a variety of stimuli. Cytosolic cytochrome c is necessary for the initiation of the apoptotic program, suggesting a possible connection between Bcl-2 and cytochrome c, which is normally located in the mitochondrial intermembrane space. Cells undergoing apoptosis were found to have an elevation of cytochrome c in the cytosol and a corresponding decrease in the mitochondria. Overexpression of Bcl-2 prevented the efflux of cytochrome c from the mitochondria and the initiation of apoptosis. Thus, one possible role of Bcl-2 in prevention of apoptosis is to block cytochrome c release from mitochondria.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.

            Therapeutics that discriminate between the genetic makeup of normal cells and tumour cells are valuable for treating and understanding cancer. Small molecules with oncogene-selective lethality may reveal novel functions of oncoproteins and enable the creation of more selective drugs. Here we describe the mechanism of action of the selective anti-tumour agent erastin, involving the RAS-RAF-MEK signalling pathway functioning in cell proliferation, differentiation and survival. Erastin exhibits greater lethality in human tumour cells harbouring mutations in the oncogenes HRAS, KRAS or BRAF. Using affinity purification and mass spectrometry, we discovered that erastin acts through mitochondrial voltage-dependent anion channels (VDACs)--a novel target for anti-cancer drugs. We show that erastin treatment of cells harbouring oncogenic RAS causes the appearance of oxidative species and subsequent death through an oxidative, non-apoptotic mechanism. RNA-interference-mediated knockdown of VDAC2 or VDAC3 caused resistance to erastin, implicating these two VDAC isoforms in the mechanism of action of erastin. Moreover, using purified mitochondria expressing a single VDAC isoform, we found that erastin alters the permeability of the outer mitochondrial membrane. Finally, using a radiolabelled analogue and a filter-binding assay, we show that erastin binds directly to VDAC2. These results demonstrate that ligands to VDAC proteins can induce non-apoptotic cell death selectively in some tumour cells harbouring activating mutations in the RAS-RAF-MEK pathway.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mitochondrial diseases in man and mouse.

              Over the past 10 years, mitochondrial defects have been implicated in a wide variety of degenerative diseases, aging, and cancer. Studies on patients with these diseases have revealed much about the complexities of mitochondrial genetics, which involves an interplay between mutations in the mitochondrial and nuclear genomes. However, the pathophysiology of mitochondrial diseases has remained perplexing. The essential role of mitochondrial oxidative phosphorylation in cellular energy production, the generation of reactive oxygen species, and the initiation of apoptosis has suggested a number of novel mechanisms for mitochondrial pathology. The importance and interrelationship of these functions are now being studied in mouse models of mitochondrial disease.
                Bookmark

                Author and article information

                Journal
                Antioxidants (Basel)
                Antioxidants (Basel)
                antioxidants
                Antioxidants
                MDPI
                2076-3921
                06 October 2019
                October 2019
                : 8
                : 10
                : 454
                Affiliations
                [1 ]Cardiac Surgery Research Laboratory, Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck A-6020, Austria; michael.grimm@ 123456tirol-kliniken.at
                [2 ]Department of Pediatrics I, Medical University of Innsbruck, Innsbruck A-6020, Austria
                [3 ]Department of Physiology, School of Medicine, University of Puerto Rico, San Juan, PR 00936-5067, USA; sabzali.javadov@ 123456upr.edu
                [4 ]Department of Visceral, Transplant and Thoracic Surgery, Medical University of Innsbruck, Innsbruck A-6020, Austria; raimund.margreiter@ 123456tirol-kliniken.at
                [5 ]Department of Pediatrics II, Medical University of Innsbruck, Innsbruck A-6020, Austria; judith.hagenbuchner@ 123456i-med.ac.at
                Author notes
                [* ]Correspondence: andrey.kuznetsov@ 123456tirol-kliniken.at (A.V.K.); michael.j.ausserlechner@ 123456i-med.ac.at (M.J.A.); Tel.: +43-512-504-27815 (A.V.K.); +43-512-504-27748 (M.J.A.); Fax: +43-512-504-24625 (A.V.K.); +43-512-504-24680 (M.J.A.)
                Author information
                https://orcid.org/0000-0002-7024-5383
                https://orcid.org/0000-0003-1396-3407
                https://orcid.org/0000-0002-1015-2302
                Article
                antioxidants-08-00454
                10.3390/antiox8100454
                6826663
                31590423
                bbf4afaa-7ab3-42dc-9b85-f6667145e6a4
                © 2019 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 26 August 2019
                : 01 October 2019
                Categories
                Review

                heart,ischemia-reperfusion,cytoskeleton,energy metabolism,mitochondria,mitochondrial heterogeneity,preconditioning,reactive oxygen species,signaling

                Comments

                Comment on this article